Aerosolized terbutaline sulfate--an evalution of efficacy and side effects in patients with reversible airway disease.

Author: AllegraJ, GillinM, TrautleinJ

Paper Details 
Original Abstract of the Article :
Aerosolized terbutaline sulfate at a dose of 0.50 mg has been shown to produce significant bronchodilation in patients with reversible airway disease. The purpose of this study was to evaluate the safety and efficacy of 0.50 mg terbutaline aerosol used on a regular dosage schedule over a six-week pe...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/j.1552-4604.1977.tb04588.x

データ提供:米国国立医学図書館(NLM)

Aerosolized Terbutaline Sulfate: A Refreshing Oasis for Reversible Airway Disease

Reversible airway disease, a condition that affects the ability to breathe, can be like a sandstorm, making it difficult to catch your breath. Researchers are constantly seeking new ways to navigate this treacherous landscape, and aerosolized terbutaline sulfate has emerged as a potential oasis of treatment. This study investigates the efficacy and safety of this medication in patients with reversible airway disease, exploring its potential to provide relief from the debilitating effects of this condition.

A Breath of Fresh Air: Aerosolized Terbutaline Sulfate for Relief

This study explores the potential of aerosolized terbutaline sulfate as a treatment for reversible airway disease. The authors, like skilled desert explorers, demonstrate that this medication can effectively improve lung function, providing significant bronchodilation and easing the symptoms of this condition. This research suggests that aerosolized terbutaline sulfate, like a refreshing oasis in the desert, can offer relief from the challenges of reversible airway disease.

Finding a Path Through the Sandstorm: Managing Reversible Airway Disease

The research on aerosolized terbutaline sulfate offers a beacon of hope in the challenging world of reversible airway disease. Its potential to improve lung function and provide relief from symptoms suggests a promising path for managing this condition. This study, like a well-charted map, guides us towards a better understanding of this medication and its role in combating reversible airway disease.

Dr.Camel's Conclusion

The desert of reversible airway disease can be a daunting place, but this study offers a refreshing oasis of treatment. Aerosolized terbutaline sulfate, with its potential for effective bronchodilation, presents a potentially valuable tool for managing this condition. As we continue to explore the vast landscape of respiratory ailments, this research offers a promising path towards easier breathing and improved quality of life.

Date :
  1. Date Completed 1977-03-15
  2. Date Revised 2019-08-23
Further Info :

Pubmed ID

319119

DOI: Digital Object Identifier

10.1002/j.1552-4604.1977.tb04588.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.